companydata.dkcompanydata.dk

GLOBE PHARMA ApS: Financial statements 2024

CVR: 36493119

Source: annual report 2024, Danish Business Authority

01/07/202330/06/2024

GLOBE PHARMA ApS (CVR 36493119) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,359,098 and a net result of DKK 738,896 compared with DKK 458,450 the year before. That is an increase of 58.8% compared with the year before. Equity in the 2024 report amounted to DKK 789,564. The solvency ratio was 23.2%. The company had 1 employee in the financial year.

Gross Profit
DKK 2,359,098
Profit/Loss
DKK 738,896
Equity
DKK 789,564
Total Assets
DKK 3,409,226
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.4 mio.739 t.790 t.1
2023-1.5 mio.458 t.509 t.1
2022-2.2 mio.1.1 mio.1.1 mio.1
2021-1.6 mio.484 t.535 t.1
2020-1.6 mio.541 t.592 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

About GLOBE PHARMA ApS

GLOBE PHARMA ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Ravn. The company is owned by RAVNEN HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,623,545 and a net result of DKK 460,318 compared with DKK 738,896 the year before. Equity in the 2025 report amounted to DKK 511,882.

Source: annual report 2025, Danish Business Authority